Milton, MA, United States of America

Timothy J Maher

This inventor holds 4 USPTO granted patents. Top assignees: Massachusetts Institute of Technology, Interneuron Pharmaceuticals, Inc.. Active years: 1986-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1986-1991

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Timothy J Maher

Introduction

Timothy J Maher is an accomplished inventor based in Milton, MA (US). He holds a total of 4 patents that focus on methods related to appetite control and the enhancement of sympathomimetic amines. His work has contributed significantly to the fields of pharmacology and nutrition.

Latest Patents

Among his latest patents is a method for decreasing appetite, which involves a composition that combines an indirect-acting sympathomimetic drug with tyrosine or a tyrosine precursor. The drugs mentioned in this patent include phenylpropanolamine, amphetamine, or ephedrine. The inclusion of tyrosine is intended to enhance the appetite-suppressing effects of these drugs. Another notable patent is for a method that enhances the effect of indirect-acting sympathomimetic amines. In this case, tyrosine or a precursor is administered alongside the drug to increase norepinephrine release in sympathetic neuron synapses.

Career Highlights

Timothy has worked with prestigious institutions, including the Massachusetts Institute of Technology and Interneuron Pharmaceuticals, Inc. His research and innovations have made a significant impact in the areas of appetite regulation and drug efficacy.

Collaborations

One of his notable collaborators is Richard J Wurtman, with whom he has worked on various projects related to his patents.

Conclusion

Timothy J Maher is a notable inventor whose work in appetite control and pharmacology has led to valuable innovations. His contributions continue to influence the field and provide insights into the mechanisms of drug action.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…